Peter Ellmark

Company: Alligator Bioscience AB

Job title: Chief Scientific Officer

Seminars:

Harnessing Tumour Models to Explore CD40 Therapies on Tumour Myeloid Cell Populations 3:15 pm

Discussing the relevance and translational potential of 2D culture models for understanding the mechanisms and optimizing CD40-based therapies Examining the effects of CD40 agonists or combination therapies on myeloid cell polarization, antigen presentation, and T cell activation Presenting and interpreting data from dissociated tumour models in 2D culture to elucidate the mechanistic insights and identify…Read more

day: Conference Day One